Interestingly, evidence now shows that NF-κB subunit p65 can bind directly to the GLI1 promoter region, and inhibition of NF-κB decreased GLI1 activity in breast cancer cells [20]. This evidence concerns the gene NFKB1 and breast carcinoma.